Table 1 Clinical characteristics of amyloidosis patients at presentation (N = 56)
From: Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis
Characteristics | |
|---|---|
Male/Female | 39/17 |
Age (years) | |
Median | 67 |
Range | (21–83) |
Serum M-Protein (g/L) 1 | (N = 18) |
Mean | 0.5 |
Median | 0.2 |
Range | (0–4.0) |
24-hour Urine Protein (g) 1 | (N = 47) |
Mean | 3.2 |
Median | 0.4 |
Range | (0–26.9) |
BMPC* (%) 2 | (N = 53) |
Mean | 8 |
Median | 5 |
Range | (0–50) |
B 2 Microglobulin (mg/dl) 1 | (N = 47) |
Mean | 3.4 |
Median | 2.7 |
Range | (0.3–18.4) |
Serum albumin (g/L) 1 | (N = 53) |
Mean | 3.4 |
Median | 3.6 |
Range | (1.0–5.4) |
Immunoglobulin type Heavy Chain | (N = 12) |
IgA (%) | 2 (17) |
IgG (%) | 9 (75) |
IgM (%) | 1 (8) |
Unknown | 0 |
Light Chain | (N = 25) |
λ | 18 (72) |
κ | 7 (28) |
History of VTD Personal | |
Yes (%) | 1 (2) |
No (%) | 53 (94) |
Unknown (%) | 2 (4) |
Family | |
No (%) | 52 (93) |
Unknown (%) | 4 (7) |